Which of the following is a recently approved drug for post paum depression: (A) Brexanolone, (B) Calpacizumab, (C) Solriamfetol, (D) Siponimod
Answer is A. The uses of above drugs are:Brexanolone: Post paum depressionCalpacizumab: Thrombotic thrombocytopenic purpuraSolriamfetol: Excessive sleepiness in narcolepsy or sleep apneaSiponimod: Mutliple sclerosis